Compared with NSE, progastrin-releasing peptide (ProGRP) is more sensitive and specific in the detection of small cell lung cancer; thus, it has been used to complement NSE in the diagnosis and monitoring of SCLC, especially in its early stages [15]. The gene discussed is ENO2; the disease is small cell lung carcinoma.